Overall Technical outlook

Price Summary

On 2025-04-25, SUNPHARMA's stock started at 1806.0, reached a high of 1815.5, fell to 1764.2, and ended -1.03% down at 1787.4, with 2036791 shares traded.
The stock reached its highest price of 1948.7 and its lowest price of 1429.85 during the 52-week period.
The projected price range for Sun Pharmaceutical Industries Limited is between 1500.0 and 2450.0, with an expected mean price of 2047.8918, according to 37 analysts.

Technicals

Support and Resistance: The price for SUNPHARMA at 1787.4 is supported by the 1734.25 level and faces resistance at 1800.85. This range indicates key levels where the price may find buyers near 1734.25 and sellers near 1800.85, defining a trading range.
SUNPHARMA supportResistance 51c3f2
Support/Resistance for SUNPHARMA


Aroon: The AROON indicator is currently reflecting a strong bullish trend, as the Aroon Up has risen and the Aroon Oscillator has reversed. These signals suggest a reversal to an upward trend, indicating that market sentiment is shifting towards optimism. Investors might expect further upward momentum, with the potential for continued gains in the market.
SUNPHARMA aroon 51c3f2
Aroon chart for Sun Pharmaceutical Industries Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
SUNPHARMA bbands 51c3f2
Bolinger Bands chart for Sun Pharmaceutical Industries Limited


Parabolic SAR: The PSAR continues its bullish outlook, establishing a support level that could help sustain the current upward trend. This level of support may act as a cushion against potential downturns, indicating continued strength in the market's bullish momentum for SUNPHARMA.
SUNPHARMA psar 51c3f2
Parabolic Stop and Reverse chart for Sun Pharmaceutical Industries Limited


Stochastic: The stochastic indicator shows a bullish signal, with the K-line exceeding both the D-line and the 80 mark. This setup suggests strong upward momentum, implying that the market may continue to rise. Investors could consider this a favorable sign for continued market growth for Sun Pharmaceutical Industries Limited.
SUNPHARMA stoch 51c3f2
Stochastic chart for Sun Pharmaceutical Industries Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position for Sun Pharmaceutical Industries Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
SUNPHARMA trippleSMA 51c3f2
Tripple SMA chart for Sun Pharmaceutical Industries Limited


Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.